A carregar...
Lack of cardioprotection from subcutaneously and preischemic administered Liraglutide in a closed chest porcine ischemia reperfusion model
BACKGROUND: Glucagon-like peptide 1 (GLP1) analogues are promising new treatment options for patients with type 2 diabetes, but may have both potentially beneficial and harmful cardiovascular effects. This may also be the case for the analogues of GLP1 for clinical use. The present study examined th...
Na minha lista:
| Main Authors: | , , , , , |
|---|---|
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2009
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2728095/ https://ncbi.nlm.nih.gov/pubmed/19627582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1471-2261-9-31 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|